130 related articles for article (PubMed ID: 11477732)
1. Sputum processing for evaluation of inflammatory mediators.
Kim JS; Hackley GH; Okamoto K; Rubin BK
Pediatr Pulmonol; 2001 Aug; 32(2):152-8. PubMed ID: 11477732
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
3. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.
Woolhouse IS; Bayley DL; Stockley RA
Thorax; 2002 Aug; 57(8):667-71. PubMed ID: 12149524
[TBL] [Abstract][Full Text] [Related]
4. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics.
Perks B; Shute JK
Am J Respir Crit Care Med; 2000 Nov; 162(5):1767-72. PubMed ID: 11069810
[TBL] [Abstract][Full Text] [Related]
5. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis.
Stites SW; Walters B; O'Brien-Ladner AR; Bailey K; Wesselius LJ
Chest; 1998 Sep; 114(3):814-9. PubMed ID: 9743172
[TBL] [Abstract][Full Text] [Related]
6. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
Shah PL; Scott SF; Knight RA; Hodson ME
Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015
[TBL] [Abstract][Full Text] [Related]
7. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.
Richman-Eisenstat JB; Jorens PG; Hébert CA; Ueki I; Nadel JA
Am J Physiol; 1993 Apr; 264(4 Pt 1):L413-8. PubMed ID: 8476069
[TBL] [Abstract][Full Text] [Related]
10. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
[TBL] [Abstract][Full Text] [Related]
11. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development.
Jain R; Baines A; Khan U; Wagner BD; Sagel SD
J Cyst Fibros; 2021 Jan; 20(1):50-56. PubMed ID: 32622665
[TBL] [Abstract][Full Text] [Related]
13. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
[TBL] [Abstract][Full Text] [Related]
14. Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.
Kummarapurugu AB; Zheng S; Pulsipher A; Savage JR; Ma J; Rubin BK; Kennedy TP; Voynow JA
Am J Respir Cell Mol Biol; 2021 Feb; 64(2):260-267. PubMed ID: 33264072
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
16. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.
Worlitzsch D; Herberth G; Ulrich M; Döring G
Eur Respir J; 1998 Feb; 11(2):377-83. PubMed ID: 9551742
[TBL] [Abstract][Full Text] [Related]
17. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
18. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro.
Rubin BK; Kater AP; Goldstein AL
Chest; 2006 Nov; 130(5):1433-40. PubMed ID: 17099021
[TBL] [Abstract][Full Text] [Related]
19. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis.
Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE
J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
